Quick Takeaways
- Alyeska Investment Group, L.P. filed SCHEDULE 13G for Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Alyeska Investment Group, L.P. disclosed 9.9% ownership in Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 9.9% | 302,252 | 0 | 302,252 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 9.9% | 302,252 | 0 | 302,252 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 9.9% | 302,252 | 0 | 302,252 | Anand Parekh | Anand Parekh | Self |